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Background: The eukaryotic translation initiation factor 5A1 (eIF5A1) is a highly conserved protein involved in
many cellular processes including cell division, translation, apoptosis, and inflammation. Induction of apoptosis is
the only function of eIF5A1 that is known to be independent of post-translational hypusine modification. In the
present study, we investigated the involvement of mitogen- and stress-activated protein kinases during apoptosis
of A549 lung cancer cells infected with adenovirus expressing eIF5A1 or a mutant of eIF5A1 that cannot be
hypusinated (eIF5A1K50A).
Methods: Using adenoviral-mediated transfection of human A549 lung cancer cells to over-express eIF5A1 and
eIF5A1K50A, the mechanism by which unhypusinated eIF5A1 induces apoptosis was investigated by Western
blotting, flow cytometry, and use of MAPK and p53 inhibitors.
Results: Phosphorylation of ERK, p38 MAPK, and JNK was observed in response to adenovirus-mediated over-
expression of eIF5A1 or eIF5A1K50A, along with phosphorylation and stabilization of the p53 tumor suppressor
protein. Synthetic inhibitors of p38 and JNK kinase activity, but not inhibitors of ERK1/2 or p53 activity, significantly
inhibited apoptosis induced by Ad-eIF5A1. Importantly, normal lung cells were more resistant to apoptosis induced
by eIF5A1 and eIF5A1K50A than A549 lung cancer cells.
Conclusions: Collectively these data indicate that p38 and JNK MAP kinase signaling are important for eIF5A1-
induced cell death and that induction of apoptosis was not dependent on p53 activity.
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Eukaryotic translation initiation factor 5A (eIF5A) is a
highly conserved protein that is post-translationally
modified on a conserved lysine residue by two enzymes,
deoxyhypusine synthase (DHS) and deoxyhypusine hy-
droxylase (DOHH), which transfer a butylamine group
from spermidine to a conserved lysine residue to produce
the amino acid, hypusine. Two isoforms of eIF5A sharing
84% homology exist in humans but appear to have distinct
biological functions [1]. EIF5A1 is ubiquitously expressed
in all examined cell types and is highly expressed in* Correspondence: jet@sciborg.uwaterloo.ca
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reproduction in any medium, provided the orproliferating cells while eIF5A2 has restricted expression
[2] and has been proposed to be an oncogene [3-5].
Although the physiological role of eIF5A1 has not been
fully elucidated, it has been found to function both as a
translation elongation factor during protein synthesis
[6] and as a cytoplasmic shuttling protein regulating
mRNA transport [7,8]. EIF5A1 has also been implicated
in the regulation of cell proliferation [9], inflammation
[10], and apoptosis [11-16]. The pro-apoptotic function
of eIF5A1 appears to be the only activity of eIF5A1 that
is independent of hypusine modification [13,15,16], and
over-expression of eIF5A1 mutated at the hypusination
site, lysine 50, induces apoptosis in a wide range of
cancer cell types, including colon [13], cervical [15], andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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onstrated the anti-tumoral activity of eIF5A1 in animal
models of lung cancer, melanoma [14], and multiple
myeloma [16]. Apoptosis induced by an accumulation
of non-hypusine-modified eIF5A1 has been correlated
with loss of mitochondrial membrane potential and
activation of caspases [15,17] as well as up-regulation of
p53 [13,14]. However, eIF5A1 also induces apoptosis in
p53-negative cell lines [14,15], suggesting activation of
p53-independent apoptotic pathways. Suppression of
eIF5A1 expression using RNA interference reduces acti-
vation of mitogen-activated protein kinases (MAPKs)
[16,17] and can protect cells from apoptosis induced by
cytotoxic drugs and cytokines [12,15,17].
MAPKs are serine/threonine protein kinases that par-
ticipate in intracellular signaling during proliferation,
differentiation, cellular stress responses, and apoptosis
[18]. Activation of MAPKs, including extracelluar signal-
regulated kinases 1 and 2 (ERK1/2), p38 MAPK, and the
stress activated protein kinase (SAPK)/c-Jun NH2-terminal
kinase (JNK), has been implicated in the activity of
numerous chemotherapy and genotoxic drugs. MAPK
can regulate apoptosis through specific phosphorylation
of downstream mediators of apoptosis, including the
tumor suppressor p53, thus linking cellular stress
signaling and regulation of p53 activity. Phosphorylation
of p53 can regulate p53 activity by altering protein
stability, interaction with co-activators, and transcrip-
tion of target genes [19] as part of the cellular response
to stress.
Despite numerous studies documenting the anti-
tumoral activity of eIF5A1 in a wide variety of cancer
cell types, there is limited knowledge about the mecha-
nisms by which eIF5A1 modulates apoptosis. In the
present study, adenovirus-mediated over-expression of
eIF5A1 or eIF5A1K50A were found to activate ERK, p38
MAPK, and JNK coincident with the induction of apop-
tosis and phosphorylation of p53 tumor suppressor in
A549 lung cancer cells. Inhibitors of p38 and JNK at-
tenuated apoptosis by eIF5A1, suggesting that activation
of MAPK/SAPK pathways is an important feature of
eIF5A1-induced cell death. Ad-eIF5A1 also induced
MEK-dependent phosphorylation and accumulation of
p53. However, activity of p53 was not required for
eIF5A1-induced apoptosis, indicating that alternative
pathways are involved. Normal lung fibroblasts were
found to be less sensitive to eIF5A1-induced apoptosis
than A549 cells, possibly due to higher B cell lymphoma-2
(Bcl-2) levels and reduced activation of p38 MAPK.
Activation of MAPK signaling pathways and apop-
totic cell death of A549 cells were correlated to an
accumulation of unmodified eIF5A1, suggesting that
eIF5A1 anti-tumoral activity is independent of hypusine
modification.Results
Ad-eIF5A1 and Ad-eIF5AK50A induce activation of ERK
kinase, p38 MAPK, and JNK
Previous studies have demonstrated that treatment
with adenovirus eIF5A1 induces apoptosis in A549 lung
carcinoma cells and improves duration of survival in
mice bearing A549 xenograft tumors [14]. In order to
explore the signaling pathways responsible for the anti-
tumoral activity of eIF5A1, A549 cells were transduced
with increasing amounts of adenovirus expressing
eIF5A1 or a mutant of eIF5A1 that cannot be hypusinated
(eIF5A1K50A), and analyzed by immunoblot for effects
on MAPK/SAPK signaling pathways. A dose-dependent
increase in expression of eIF5A1 was observed after
infection with increasing amounts of either Ad-eIF5A1
or Ad-eIF5A1K50A (Figure 1A-B). To determine whether
the high levels of eIF5A1 produced by adenovirus resulted
in increased levels of hypusine-modified eIF5A1, two-
dimensional gel electrophoresis of adenovirus-infected
A549 cells was performed. Hypusination ensues almost
immediately following translation of eIF5A1 and, conse-
quently, the majority of eIF5A1 present in untreated
healthy cells is hypusinated (Figure 2A-B). Treatment with
the DHS inhibitor GC7, which inhibits the first enzymatic
step in the conversion of lysine to hypusine, results in ac-
cumulation of unhypusinated eIF5A1 (Figure 2A-B). A549
cells infected with Ad-eIF5A1 and Ad-eIF5A1K50A both
exhibited a substantial increase in the relative abundance
of unhypusinated (K50) eIF5A1, suggesting that the accu-
mulation of newly translated eIF5A1 generated by adeno-
virus overwhelmed the catalytic functions of DHH and
DOHH (Figure 2A-B). Ad-eIF5A1 and Ad-eIF5A1K50A
infection of A549 cells did not deplete hypusine-eIF5A1
levels (Figure 2A), indicating that the consequences of
eIF5A1 and eIF5A1K50A over-expression are due to accu-
mulation of non-modified eIF5A1 and not to depletion of
hypusine-eIF5A levels.
EIF5A1 and eIF5A1K50A over-expression both resulted
in dose-dependent phosphorylation of ERK, p38 MAPK
and JNK (Figure 1A-D) at sites associated with increased
kinase activity. A clear dose-dependent increase in phos-
phorylation of p38 in response to increasing Ad-eIF5A1
expression was observed (Figure 1C). Although expres-
sion of phosphorylated ERK decreases at the highest
Ad-eIF5A1 expression level, there is a trend towards in-
creased expression of phosphorylated ERK with increasing
viral dose (Figure 1D). Phosphorylation of p90RSK, a
kinase that is phosphorylated and activated by ERK, was also
observed in response to Ad-eIF5A1 and Ad-eIF5A1K50A,
indicating increased ERK activity (Figure 1A-B). An
increase in phosphorylated p38 and a decrease in phos-
phorylated JNK were observed when Ad-eIF5A1K50A-
infected cells were treated with the MAPK kinase
(MEK) inhibitor U1026, indicating that ERK negatively
Figure 1 Ad-eIF5A1 and Ad-eIF5A1K50A infection activate MAPK/SAPK pathways. A549 lung carcinoma cells were infected with adenovirus
expressing eIF5A1 (A) or the non-hypusinable mutant eIF5A1K50A (B) at increasing multiplicities of infection (MOI). A) A549 cells were treated with
Ad-eIF5A1 at an MOI of 5, 10, 25, 50 or 80 and Ad-LacZ at an MOI of 80. B) A549 cells were treated with Ad-eIF5A1K50A at an MOI of 5, 25, 50 or
80 and Ad-LacZ at an MOI of 80. Twenty-four hours later, a subset of infected cells were treated with 10 μM of the MEK inhibitor U1026. A, B)
Forty-eight hours after infection, cell lysate was harvested and used for western blot analysis using antibodies to eIF5A1 or the MAPK/SAPK
pathway. The data is representative of three independent experiments. Quantification of expression of phosphorylated p38 and phosphorylated
p42/p44 MAPK relative to expression of un-phosphorylated total protein from (A) is shown in (C) and (D), respectively.
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A549 cells (Figure 1B). Phosphorylation at serine 63 of
the transcription factor c-Jun, a component of the acti-
vating protein-1 (AP-1) transcriptional complex was ob-
served in response to Ad-eIF5A1 infection (Additional
file 1: Figure S1), which is consistent with activation of
SAPK/JNK [20] in response to eIF5A1.
Ad-eIF5A1 induces MEK-dependent activation and
phosphorylation of the p53 tumor suppressor protein
A549 cells have been reported to have a functional p53
tumor suppressor protein [21]. Expression of eIF5A1
has previously been correlated to p53 levels in lung
cancer cells [11,14], and in this study a dose-dependent
increase in p53 was observed in response to Ad-eIF5A1
and Ad-eIF5A1K50A infection in A549 cells (Figures 1B
and 3). Phosphorylation of p53 at serines 15, 37, and392 was also correlated with increased eIF5A1 expres-
sion (Figure 4). Phosphorylation at these sites has been
demonstrated to regulate the apoptotic activity of p53
[19]. Phosphorylation of p53 at serine 15, which has been
demonstrated to increase protein stability and activity
[22,23], may partially account for the increased p53 ex-
pression observed in response to eIF5A1. ERK1/2 and p38
MAPK have both been reported to phosphorylate p53 at
several residues, including serine 15 [24,25]. Accordingly,
we examined the effects of chemical inhibitors of p38
MAPK, JNK, and ERK on p53 phosphorylation (Figure 4).
Although inhibitors of p38 and JNK did not affect phos-
phorylation of p53 in response to Ad-eIF5A1, the MEK
inhibitor, U1026, dramatically reduced phosphorylation at
all three sites. The total expression of p53 was also some-
what reduced in U1026-treated cells, suggesting that phos-
phorylation was contributing to stability of the protein.
Figure 2 Ad-eIF5A1 and Ad-eIF5A1K50A infection results in
accumulation of unhypusinated eIF5A1. A) Two-dimensional gel
electrophoresis of lysate from A549 cells forty-eight hours after
infection with either Ad-LacZ, Ad-eIF5A1, or Ad-eIF5AK50A followed
by western blotting with eIF5A1 antibody. Cells were treated with
the DHS inhibitor, GC7, as a positive control. A short exposure of
blots from eIF5A1-overexpresing lysates is included for comparison.
B) The relative abundance of the different post-translationally modified
forms of eIF5A1 and eIF5A1K50A, including spot a (acetylated K47/K50
or acetylated K47/A50), spot b (K47/K50 or K47/A50), and spot c
(K47/Hypusine 50), was determined by densitometry.
Figure 3 Ad-eIF5A1 infection upregulates Bax and Bid. A549 lung
carcinoma cells were infected with adenovirus expressing eIF5A1 at
increasing multiplicities of infection (MOI). Adenoviral infection with
Ad-eIF5A1 (5A) was at MOI’s of 5, 10, 25 or 80 while Ad-LacZ (L) was
given at an MOI of 80. Forty-eight hours later, the cell lysate was
harvested and used for western blot analysis of Bcl-2 family proteins.
The data is representative of three independent experiments.
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of the Bcl-2 family [26,27] is involved in the initiation of
apoptosis that is central to the tumor suppressor ac-
tivity of p53. Increased expression of the pro-apoptotic
Bcl-2 family members Bax and Bid, but not Bim, was
observed following Ad-eIF5A1 infection (Figure 3),
suggesting that p53-mediated induction of Bcl-2 pro-
apoptotic family members may contribute to eIF5A1-
induced apoptosis. Quantitative reverse transcription
PCR (RT-qPCR) amplification of tumor necrosis factor
receptor 1 (TNFR1), a p53 transcriptional target, revealed
that Ad-eIF5A1 infection resulted in increased tran-
scriptional activity of p53 (Figure 5). Expression levels
of both TNFR1 and p53 mRNA increased in response
to Ad-eIF5A1 infection and this up-regulation was
inhibited by both U1026 and pifithrin-α, an inhibitor
of p53 activity. This indicates that over-expression of
unhypusinated eIF5A1 resulted in increased p53 tran-
scriptional activity that is at least partially dependent on
MEK activity.Inhibitors of p38 MAPK and JNK protect A549 cells from
Ad-eIF5A1-induced apoptosis
ERK, p38, and JNK signaling pathways are involved in
both apoptosis and cell growth, depending on the cell
type and stimulus. The dependence of eIF5A1 on activa-
tion of p38, JNK and ERK for induction of apoptosis
was evaluated by pre-treating A549 cells with specific
inhibitors to these kinases and then inducing apoptosis
by infecting the cells with Ad-eIF5A1 (Figure 6). Since
Ad-eIF5A1 infection is associated with increased ex-
pression and activity of p53 (Figures 3, 4, and 5), cells
were also pre-treated with pifithrin-α in order to deter-
mine whether eIF5A1-induced apoptosis is dependent
on p53 activity in A549 cells. MEK inhibition did not
significantly affect induction of apoptosis by Ad-eIF5A1.
Inhibition of p38 and JNK both significantly reduced
eIF5A1-induced apoptosis while use of both inhibitors
in combination inhibited apoptosis by approximately
50% (p < 0.001), suggesting that activation of p38 and
JNK are both important in the induction of apoptosis by
Figure 4 Ad-eIF5A1 infection induces increased expression and
phosphorylation of p53 tumor suppressor protein. A549 lung
carcinoma cells were infected with adenovirus expressing either
LacZ (L) or eIF5A1 (5A). Four hours after infection, the media was
replaced with media containing either DMSO, 10 μM of p38
inhibitor SB203580 (SB), 10 μM of the JNK inhibitor SP600125 (JNK),
or 10 μM of the MEK inhibitor U1026. Forty-eight hours later the cell
lysate was harvested. Western blots were performed on the lysate
using antibodies directed against either total p53 (p53), or p53
phosphorylated on ser15, ser37, or ser392. The data is representative
of three independent experiments.
Figure 5 The increase in Ad-eIF5A1-induced p53 mRNA levels is
dependent upon p53 transcriptional activity. A549 lung
carcinoma cells were infected with adenovirus expressing LacZ or
eIF5A1 Four hours after infection, the media was replaced with
media containing either DMSO, 10 μM of the MEK inhibitor U1026,
or 30 μM of the p53 inhibitor pifithrin-α. Forty-eight hours later, total
RNA was isolated from the cells and the levels of p53 and TNFR1
mRNA expression were determined by quantitative PCR using
GAPDH as a reference gene. Mean expression relative to GAPDH
from 3 independent experiments is shown (* p < 0.05; ** p < 0.01).
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impact apoptosis resulting from Ad-eIF5A1 infection
suggesting that, although p53 is up-regulated in re-
sponse to eIF5A1, it is not required for apoptosis
(Figure 6).
Normal lung fibroblasts are resistant to Ad-eIF5A1-
induced apoptosis
The ability to kill malignant cells without harming
normal cells is an important feature of an ideal cancer
therapy drug. In order to assess the specificity of eIF5A1
over-expression for inducing apoptosis in cancer cells
rather than non-malignant cells, A549 lung carcinoma
cells and WI-38 normal lung fibroblast cells were ana-
lyzed for induction of apoptosis by Annexin/propidium
iodide (PI) staining following infection of Ad-eIF5A1 or
Ad-eIF5A1K50A (Figure 7A). EIF5A1 and eIF5A1K50A
induced apoptosis in 7% and 8% of WI-38 normal lung
fibroblast cells forty-eight hours after infection, respec-
tively. However, A549 cells were more sensitive to
eIF5A-induced apoptosis with 16% and 19% of cellsundergoing apoptosis forty-eight hours after infection
with Ad-eIF5A1 or Ad-eIF5A1K50A, respectively. Similar
results were observed seventy-two hours after infection
(Figure 7A), confirming that WI-38 cells were resistant
to eIF5A1-induced apoptosis in spite of virus-mediated
eIF5A1 expression levels comparable to those in A549
cells (Figure 7B). In contrast, the cytotoxic drug Actino-
mycin D, an inhibitor of DNA-dependent RNA synthesis,
induced comparable levels of apoptosis in both normal
and malignant cells (Figure 7A). ERK and p38 MAPK
activation in A549 lung carcinoma cells and WI-38 lung
fibroblast cells was analyzed by immunoblotting after
treatment with adenovirus (Figure 7B-D). Activation of
p38 MAPK was observed in response to Ad-eIF5A1 and
Ad-eIF5A1K50A infection in both A549 cells and WI-38
cells. However, Ad-eIF5A1 and Ad- eIF5A1K50A induced
only a modest 2-fold increase in phosphorylated p38 in
WI-38 cells. In contrast, A549 cells, which displayed greater
sensitivity to eIF5A1-induced apoptosis, exhibited a greater
than 10-fold increase in levels of phosphorylated p38
MAPK (Figure 7B-C). These data suggest that over-
expression of eIF5A1, and ensuing activation of p38
MAPK signaling, act as a more potent inducer of cell
death in malignant A549 cells than in normal lung cells.
In addition, ERK MAPK was activated in response to
Ad-eIF5A1 or Ad-eIF5A1K50A infection in malignant
A549 cells, but not in WI-38 cells (Figures 7B and 7D).
Figure 6 Induction of apoptosis by Ad-eIF5A1 infection is dependent on p38 and JNK activity. A549 lung carcinoma cells were infected
with adenovirus expressing either LacZ or eIF5A1. Four hours after infection, the media was replaced with media containing either DMSO, 10 μM
of the MEK inhibitor U1026, 10 μM of the p38 inhibitor SB203580, 10 μM of the JNK inhibitor SP600125 (JNK), 10 μM of SB203580 and SP600125
(SB + JNK), or 30 μM of the p53 inhibitor pifithrin-α. Forty-eight hours later, the cells were harvested and the percentage of cells undergoing
apoptosis was determined by Annexin/PI staining and flow cytometry. The data shown is the mean of 3 independent experiments. Statistical
significance in comparison to Ad-eIF5A1 infected cells treated with DMSO is indicated (* p < 0.05; ** p < 0.01; *** p < 0.001).
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found to be much higher in WI-38 cells than A549 cells
(Figure 7B), which may also have contributed to survival
of these cells.
Discussion
The development of cancer gene therapies requires agents
that target pathways that maximize anti-cancer activity.
EIF5A1 has been identified as a viable cancer target that
can be adapted for use in gene therapy approaches since
its over-expression has been demonstrated to induce
apoptosis in a wide variety of cancer types [11,13-16]. As
well, suppression of hypusinated eIF5A1 using a small
interfering RNA (siRNA) has been shown to inhibit activa-
tion of Nuclear Factor kappa B (NF-κB) and ERK MAPK
in multiple myeloma cells [16] and to potentiate the pro-
apoptotic activity of an eIF5AK50R expression plasmid.
SNS01-T, a nanoparticle containing an eIF5AK50R expres-
sion plasmid and an eIF5A1 siRNA, is currently being
evaluated in a clinical trial in patients with advanced
multiple myeloma [http://www.clinicaltrials.gov; Identifier:
NCT01435720].
Although the precise mechanism underlying the role
of eIF5A1 in cell death is unknown, it can induce apop-
tosis in a p53-dependent [11] or independent manner
[13,14] and activate the intrinsic mitochondrial pathway
of apoptosis [15]. In this study, adenoviral-mediated
over-expression of eIF5A1 or eIF5AK50A was found to
induce apoptosis in A549 lung cancer cells. The similar-
ity in cellular response to eIF5A1 and eIF5A1K50A over-
expression can be attributed to the rate-limiting activityof DHS and DOHH [13,28] available to modify the large
amounts of newly translated eIF5A1 generated by the virus.
Indeed, a disproportionate accumulation of unhypusinated
relative to hypusinated eIF5A1 that correlated with the
induction of apoptosis was observed in the present study
following Ad-eIF5A1 infection of A549 cells. Another im-
portant observation is that apoptosis induced by Ad-
eIF5A1 or Ad-eIF5A1K50A infection was not correlated to
a reduction in hypusine-eIF5A levels, suggesting that the
apoptotic response is not a result of depletion of the
hypusinated form of the protein.
MAPK signaling pathways can induce either cell
proliferation or cell death depending on the cell type
and stimulus. Infection of A549 cells with Ad-eIF5A1 or
Ad-eIF5A1K50A induced activation of ERK, p38, and JNK
MAPKs. ERK can antagonize apoptosis by phosphoryla-
ting pro-apoptotic Bcl-2 proteins, e.g., Bim, and inhibiting
their function [29,30]. ERK can also promote apoptosis
by binding and phosphorylating the tumor suppressor
p53 on serine 15 [31] and up-regulating pro-apoptotic
Bcl-2 proteins such as Bax [32]. The p38 and JNK MAPK
pathways are activated by a variety of cell stressors, includ-
ing ultraviolet light (UV), radiation, cytotoxic drugs, and
cytokines such as tumor necrosis factor alpha and inter-
leukin 1. Activation of these pathways is often correlated
with stress-related apoptosis, and inhibition of p38 and
JNK has been demonstrated to prevent apoptosis resulting
from a wide variety of stressors, including UV [33], cer-
amide [34], and genotoxic stress [35]. Inhibitors of p38
and JNK inhibited apoptosis of A549 cells in response to
Ad-eIF5A1 in the present study, indicating that activation
Figure 7 A549 lung carcinoma cells are more susceptible to eIF5A1-induced apoptosis than normal lung cells. A549 lung carcinoma cells
or WI38 normal lung fibroblasts cells were infected at an MOI of 80 with adenovirus expressing LacZ, eIF5A1, or eIF5A1K50A. Four hours after
infection, the media was replaced with fresh media and cells were harvested forty-eight and seventy-two hours later hours later. (A) A549 and
WI38 cells infected with adenovirus were labeled with Annexin/PI and the percentage of cells undergoing apoptosis was determined by flow
cytometry analysis. The data shown is the mean of 3 independent experiments. Statistical significance in comparison to paired A549 cells is
indicated (* p < 0.05; ** p < 0.01; *** p < 0.001). (B) Forty-eight hours after infection, cell lysates were harvested and the expression of eIF5A,
MAPK/SAPK proteins, and Bcl-2 was examined by western blot analysis. The blots shown are representative of three independent experiments.
Quantification of expression of phosphorylated p38 (C) and phosphorylated p42/p44 ERK MAPK (D) relative to expression of unphosphorylated
total protein.
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accumulation of unmodified eIF5A1. A member of the
AP-1 transcription factor family, c-Jun, has been impli-
cated in both cell survival and apoptosis [36] depending
on the tissue and stimulus. The transcriptional activity of
c-Jun and its ability to either enhance or protect against
apoptosis are largely regulated by JNK-mediated phos-
phorylation of its transactivation domain at serines 63 and
73 [37,38]. P38 MAPK has also been reported to phos-
phorylate c-Jun at serine 63 in T lymphocytes [39]. In
accordance with an increase in JNK and p38 MAPK activ-
ity, phosphorylation of c-Jun at serine 63 was observed
following Ad-eIF5A1 infection, suggesting that eIF5A1-
induced apoptosis may involve the AP-1 transcription
factor complex.The p53 tumor suppressor protein is activated by a var-
iety of cellular stressors including reactive oxygen species,
DNA damage, hypoxia and oncogene stimulation, and
assists in the cellular response to stress by regulating cell
growth and apoptosis. Post-translational modifications,
including phosphorylation, modify the activity of p53 by
regulating protein stability and enhancing DNA binding
and transcriptional activity. Phosphorylation of p53 at
serine 15 contributes to stability of p53 by interfering with
binding to the E3 ubiquitin ligase, Mdm2 [22], and is also
critical for the transactivation activity of p53 by promoting
its association with the p300 coactivator protein [23].
Intracellular signaling resulting from DNA damage
leads to phosphorylation of p53 at serines 15, 20 and 37
resulting in decreased association with Mdm2 [40],
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[22]. Phosphorylation of serine 15 is critical for p53-
induced apoptosis [41] and has been associated with
increased expression of p53-responsive pro-apoptotic
genes [42]. Oligomerization of p53, which is critical to its
transcriptional activity, is regulated by phosphorylation at
serine 392 [43]. The involvement of ERK in the regulation
of p53 stability and activity through direct phosphoryl-
ation has long been recognized [44]. In the present
study, eIF5A1 over-expression induced MEK-dependent
accumulation and phosphorylation of the p53 tumor
suppressor protein on serines 15, 37, and 392, as well as
up-regulation of the p53-responsive genes, TNFR1 and p53.
However, in spite of increased p53 activity in Ad-eIF5A1
-infected cells, an inhibitor of p53 was not sufficient to in-
hibit eIF5A1-induced apoptosis. Thus, apoptosis of A549
lung cancer cells induced by eIF5A1 does not appear to be
dependent on p53 activity, although increased expression/
stability of p53 induced by eIF5A1 may lower the apoptotic
threshold [45] and thereby contribute to the pro-apoptotic
activity of eIF5A.
Increased expression of Bax and the BH3-only pro-
tein, Bid, was observed in response to Ad-eIF5A1 over-
expression, both being pro-apoptotic proteins that are
transcriptionally regulated by stress-activated p53 [27].
Hypusine-modified eIF5A1 has been proposed to act as
a tumor suppressor in Eμ-myc lymphomagenesis in
mice, in part by promoting expression of Bax [46].
However, in the present study, increased expression of
both p53 and Bax was correlated with an accumulation
of unmodified eIF5A, since hypusine-eIF5A1 levels were
relatively unaffected by Ad-eIF5A1 infection. The pro-
apoptotic BH3-only Bcl-2 family member, Bid, is
cleaved by caspase 8 and then interacts with other pro-
apoptotic Bcl-2 family members, specifically Bax and
Bak, to connect activation of the death receptor path-
way to the internal mitochondrial apoptosis pathway. In
contrast to what is observed in the event of death
receptor-mediated apoptosis, cleavage of Bid to tBid
was not apparent during eIF5A1-induced apoptosis,
although increased expression of full length Bid was
observed. Although tBid is the form of Bid typically
associated with the induction of apoptosis, full-length
Bid has been found to associate with the mitochondrial
membrane and promote apoptosis in hippocampal neu-
rons [47]. While tBid is typically observed in the late
stages of apoptosis [48], full-length Bid has been
reported to regulate the activation of Bax during apop-
tosis by facilitating its oligomerization and insertion
into the mitochondrial membrane [49].
Malignant cells often display increased sensitivity to
chemotherapy drugs and radiation. Although the mo-
lecular pathways involved in this increased sensitivity
have not been completely elucidated, the sensitizationof oncogenically-transformed cells to cytotoxic stresses
has been attributed to the potentiation of JNK and p38
MAPK activation [50]. In this study, WI-38 normal lung
cells were found to be more resistant than transformed
A549 cells to eIF5A1-induced apoptosis. Infection with
adenovirus expressing eIF5A1 or eIF5A1K50A caused an
induction of p38 and ERK MAPK phosphorylation in
A549 cells, but had a more modest effect on p38 phosphor-
ylation in WI-38 cells, suggesting that potentiation of p38
MAPK activation may have contributed to the increased
sensitivity of A549 cells to Ad-eIF5A1 infection.
Conclusions
In summary, this study has identified the activation of
MAPKs as an important step in the signaling cascade that
leads to the induction of p53-independent apoptotic cell
death in response to over-expression of unhypusinated
eIF5A1 in A549 lung carcinoma cells. The importance of
p38 and JNK activation during eIF5A1-induced apoptosis
is highlighted by the ability of inhibitors of these MAPKs
to inhibit apoptosis ensuing from Ad-eIF5A1 infection.
Furthermore, malignant A549 cells demonstrated en-
hanced sensitivity to eIF5A1-induced apoptosis compared
to normal lung cells, suggesting that eIF5A1-based therapy
may spare normal tissues. This work emphasizes the po-




The DHS inhibitor, N1-guanyl-1,7-diaminoheptane (GC7)
was purchased from Biosearch Technologies and used at a
concentration of 50 μM. The MEK inhibitor U1026, the
p38 inhibitor SB203580, the JNK inhibitor SP600125,
and the p53 inhibitor pifithrin-α were obtained from
Calbiochem. The FITC Annexin V Apoptosis Detection
Kit II was obtained from BD Pharmingen. BD Transduc-
tion Laboratories and Calbiochem supplied the eIF5A and
β-actin antibodies, respectively. All other primary anti-
bodies were purchased from Cell Signaling Technology.
Horseradish peroxidase (HRP)-conjugated secondary anti-
bodies were purchased from Sigma-Aldrich. PCR primers
were obtained from Sigma-Aldrich and iQ SYBR Green
Supermix was obtained from Bio-Rad.
Cell culture, drug treatment, and infection with
adenovirus
A549 human lung adenocarcinoma cells and WI-38
human normal lung fibroblast cells were obtained from
the American Type Culture Collection. Both cell lines
were maintained in RPMI 1640 supplemented with 1 mM
sodium pyruvate and 10% fetal bovine serum (FBS).
Adenoviral vectors (Adenovirus 5 serotype, E1 and E3-
deleted) expressing β-galactosidase (LacZ), eIF5A1, and
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(13). For adenovirus-mediated transfection, cells were
seeded at 100,000 cells per well on a 24-well tissue culture
plate and incubated with adenovirus constructs at multi-
plicities of infection (MOI), the ratio of the number of
infectious viral particles to the number of target cells,
ranging from 5 to 80 in medium containing 0.5% FBS.
Four hours later, the media was replaced with growth
media or growth media containing 10 μM of the inhibi-
tors U1026, SB203580, SP600125, or 30 μM of pifithrin.
Dimethylsulfoxide (DMSO) was included as a vehicle
control.
SDS-PAGE and western blotting
Cell lysate was prepared in lysis buffer [62.5 mM Tris–
HCl (pH 7.2), 2% SDS, 10% glycerol, protease inhibitors]
followed by brief sonication. Protein concentration
was quantified using the Bicinchoninic Acid Kit (Sigma-
Aldrich). One to ten micrograms of protein was separated
by SDS-PAGE and western blot analysis was performed by
incubating with primary antibodies for either one hour
(eIF5A, β-actin) or overnight at 4°C (all other antibodies).
After incubation with HRP-conjugated secondary anti-
bodies, the antibody-protein complexes were visualized
using enhanced chemiluminescence (GE Health). Densi-
tometry analysis was performed using TotalLab TL100
vs2006 software. In order to distinguish between the
different post-translational modification states of eIF5A,
two-dimensional gel electrophoresis followed by west-
ern blot analysis using eIF5A antibody was performed
as described [13]. Briefly, cell lysates were harvested in
cold lysis buffer (7 M Urea, 2 M Thiourea, 30 mM Tris,
4% CHAPS, 1 × protease inhibitor cocktail), loaded on
Immobiline™ Drystrips (GE Healthcare, pH 4–7, 7 cm)
followed by electrofocusing with Ethan™ IPGphor II™
using the following program: 500 V 0.5 hr, Grad 1000 V
0.5 hr, Grad 5000 V 1.5 h, 5000 V 6 hr, 500 V 5 hr.
Proteins were then fractionated on a 12% SDS-PAGE
gel, transferred to a PVDF membrane, and eIF5A post-
translational modified forms were identified by blotting
with an antibody against eIF5A1.
RT-qPCR
Total RNA was isolated from cells infected with adeno-
viral constructs using the GenElute™ Mammalian Total
RNA Miniprep Kit (Sigma-Aldrich). Reverse transcrip-
tion was performed on 1.2 micrograms of total RNA
using AMV reverse transcriptase (Roche Applied Science)
according to the manufacturer’s instructions. PCR reac-
tions contained 500 nM of each primer, 1× of iQ SYBR
Green Supermix (Bio-Rad), and 1 μL of cDNA. Real time
PCR was performed in a MiniOpticon Real Time PCR De-
tection System (Bio-Rad) for 40 cycles using glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH) as a referencegene. The tumor suppressor p53 was amplified using the
following primers [11]: forward 5′-CGCTGCTCAGATAG
CGATGGTC-3′; reverse 5′-CTTCTTTGGCTGGGGAG
AGGAG-3′. The primers used to amplify tumor necrosis
factor receptor 1 (TNFR1) were the following: forward 5′-
ATCTCTTCTTGCACAGTGG-3′; reverse 5′-CAATGG
AGTAGAGCTTGGAC-3′. The primers used to amplify
the housekeeping gene GAPDH were: forward 5′-CTGTA
GCCCCCATGTTCGTCAT-3′; and reverse 5′ –CCACC
ACCCTGTTGCTGTAG-3′.
Apoptosis assays
Apoptosis was quantified by labeling cells with Annexin
V-FITC and propidium iodide using the FITC Annexin
V Apoptosis Detection Kit II, according to the manu-
facturer’s instructions, followed by analysis on a BD
FACSVantage SE system (BD Bioscience) with an argon
laser source. A minimum of five thousand cells was
counted and the data was analyzed using WinMDI 2.8
software.
Statistics
Student’s t-test was used for statistical analysis. Signifi-
cance was determined by a confidence level above 95%
(P < 0.05).
Additional file
Additional file 1: Figure S1. A549 lung carcinoma cells were infected
with adenovirus expressing either LacZ (L) or eIF5A1 (5A). A) Forty-eight
hours later the cell lysate was harvested and analyzed by western blot
analysis for expression of phosphorylated c-Jun (ser63), p53, or eIF5A.
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